| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $62K | -37.4% | -51.6% |
| Cost of Revenue | $437K | +11.5% | +30.1% |
| Gross Profit | -$375K | -28.0% | -80.3% |
| R&D Expense | $229K | -33.0% | -44.3% |
| Operating Income | -$2.4M | +18.8% | +70.1% |
| Pre-tax Income | $8.6M | +327.2% | +189.7% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $468K | +524.0% | +143.8% |
| Accounts Receivable | $87K | +29.9% | -68.2% |
| Inventory | $8K | -99.8% | -91.8% |
| Current Assets | $1.8M | +18.4% | +25.8% |
| Total Assets | $6.7M | -0.2% | -8.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$895K | — | — |
| Investing Cash Flow | -$30K | — | — |
| Financing Cash Flow | $2.1M | — | — |
| — |
| — |
| Net Income | $8.6M | +327.2% | +146.6% |
| EPS (Basic) | $3.06 | +315.5% | +143.5% |
| EPS (Diluted) | $2.92 | +305.6% | +141.5% |
| $17.8M |
| -39.3% |
| -29.2% |
| Total Liabilities | $24.5M | -32.3% | -3.7% |
| Stockholders' Equity | -$17.8M | +39.6% | +1.6% |